Search Results for 'Protease'

Global Bakery Enzymes Market Research Report- Forecast till 2023

Global Bakery Enzymes Market Research Report: By Type (Carbohydrates, Proteases, Lipases, and Others), By Application (Bread, Biscuits & Cookies, Cake & Pastry, and Others), By Region (North America, Europe, Asia Pacific, Row) – Forecast Till 2023

by Dipak Rathod (few years ago!)

Global Human Coagulation Factor VII Market Report 2017(Application:Hemophilia Treatment/Surgery)

Global Human Coagulation Factor VII Market Report 2017(Application:Hemophilia Treatment/Surgery) Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class.

by Marco (few years ago!)

Global Food Enzymes Market : Market Growth, Key players and Outlook to 2027

Global Food Enzymes Market : Market Growth, Key players and Outlook to 2027 Global: Food Enzymes by enzymes types (amylase, protease, lipase, cellulose) and by end users (food & beverages, meat products, dairy, bakery) - Forecast To 2027

by Akash Anand (few years ago!)

Food Enzymes Market Research Key Analysis and Forecast by 2027

Food Enzymes Market Research Key Analysis and Forecast by 2027 Global: Food Enzymes by enzymes types (amylase, protease, lipase, cellulose) and by end users (food & beverages, meat products, dairy, bakery) - Forecast To 2027

by Akash Anand (few years ago!)

Food Enzymes Market Analysis and Forecast Based on Enzymes Type and End Users Business Prospects to 2027

Food Enzymes Market Analysis and Forecast Based on Enzymes Type and End Users Business Prospects to 2027 Global: Food Enzymes by enzymes types (amylase, protease, lipase, cellulose) and by end users (food & beverages, meat products, dairy, bakery) - Forecast To 2027

by Akash Anand (few years ago!)

Food Enzymes Market Development, Trend, Segmentation, Competitive landscape, Market overview and Forecast to 2027

Food Enzymes Market Development, Trend, Segmentation, Competitive landscape, Market overview and Forecast to 2027 Global Food Enzymes by enzymes types (amylase, protease, lipase, cellulose and other stuff) and by end users (food & beverages, meat products, dairy, bakery and others) - Forecast To 2027

by Pankaj (few years ago!)

Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) – Pipeline Review, H2 2016

Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) – Pipeline Review, H2 2016 is a professional and in-depth study.

by Shirley (few years ago!)

Proteases Market In Data Centers Global Industry Analysis, size, share and Forecast 2016-2026

Proteases Market In Data Centers Global Industry Analysis, size, share and Forecast 2016-2026 Future Market Insights has announced the addition of the “ Proteases Market: Global Industry Analysis and Opportunity Assessment 2016-2026”report to their offering.

by Hussain (few years ago!)

Jared Cumming, Merck, to give a presentation at GTCbio’s Protease Inhibitors Conference

Jared Cumming, Merck, to give a presentation at GTCbio’s Protease Inhibitors Conference Jared Cumming from Merck will discuss, “Discovery of Verubecestat (MK-8931): A beta-Secretase Inhibitor in Phase 3 Clinical Development for Alzheimer’s Disease”

by Kristen Starkey (few years ago!)

AnaSpec Expands HCV NS3/4A Protease Selection

AnaSpec, Eurogentec Group is pleased to announce the expansion of our NS3/4A protease selection to include proteases from genotypes 1a, 1b, 2a, 3a and 4d. These recombinant HCV NS3/4A proteases are highly active and can be used with the SensoLyte? 490, 520, or 620 HCV Protease Assay Kits for screening of anti-HCV protease drugs.

by Tiffany Kao (few years ago!)

AnaSpec Introduces Rhodamine 110 Labeled GO(R) Peptides

Rhodamine 110 (Rh110)-labeled peptides are used in the study of a number of protease activity.

by Ping Yang (few years ago!)

GSK and Concert Pharmaceuticals form alliance to develop novel deuterium-modified drugs

GlaxoSmithKline (NYSE: GSK) and Concert Pharmaceuticals announced today that they will collaborate to develop and commercialise deuterium-containing medicines. The deal includes three of Concert?s research and development programs; namely, CTP-518, a protease inhibitor for the treatment of HIV expected to enter Phase I clinical trials in the second half of 2009, a preclinical compound for chronic

by Philip Thomson (few years ago!)

Merck Announces Interim Phase IIa Study Results of MK-7009, an Investigational Oral Hepatitis C Virus Protease Inhibitor, in Patients with Chronic Hepatitis C

Phase IIb Trial will Further Assess Efficacy, Safety and Tolerability of MK-7009

by Merck (few years ago!)

AnaSpec Launches New SensoLyte? Rh110 Long Wavelength Plasmin Activity Assay Kit

AnaSpec, known for developing sensitive, long wavelength assays, is pleased to announce the release of another long wavelength protease assay ? the SensoLyte? Rh110 Plasmin Activity Assay Kit (Ex/Em=496 nm/520 nm).